Immunome, Inc. (Nasdaq: IMNM), a biotechnology company focused on developing first-in-class and best-in-class targeted cancer ...

Biotech company CERo Therapeutics Holdings, Inc. (CERO) on Wednesday announced an agreement with the University of California ...

Immunovant will use results from its Phase III myasthenia gravis study to support pipeline candidate IMVT-1402 over the trial ...

Regenxbio reports promising microdystrophin expression data in DMD patients, with highest levels in 3-year-old. Plans FDA ...

Now, a breakthrough formula called ProstaVive is gaining momentum—claimed to be a natural yet powerful way to restore ...

A Looney Tunes Movie is like spending time with old friends — the old friends being Daffy Duck and Porky Pig, in a ...

Unlike traditional fat burners that rely on caffeine, stimulants, or appetite suppression, Mitolyn takes a unique approach by ...

During a live event, Sumanta K. Pal, MD, discusses the efficacy and safety findings from the CheckMate 274 trial of adjuvant ...

Lely has launched the Vector MFR Next, the new mixing and feeding robot that takes robotic precision feeding to a higher ...

The FDA granted orphan drug designation to HLX22 for gastric cancer, advancing global phase 3 trials to improve first-line ...

Cross-adaptation theory suggests exposure to controlled stressors can build resilience to unrelated challenges.

Bristol Myers (BMY)’ treatment of small cell lung cancer, atigotatug plus nivolumab fixed dose combination, received FDA ...